Latest filing published 17 May 2011 for ANGIOTECH PHARMACEUTICALS INC.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Jay Bernard Dent: trading record in brief
Jay Bernard Dent discloses dealings in Angiotech Pharmaceuticals Inc to SEC (Form 4). We count 9 filings; the first trade dates from 13 August 2009 and the latest from 12 May 2011.
Purchases make up the whole of the open-market record (3 purchases, €23k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
A typical purchase (the median) is worth €8,278.
Most recently, on 17 May 2011, the filings show a transaction in Angiotech Pharmaceuticals Inc. The last insider purchase was made public on 14 August 2009, 6,296 days ago. The median gap between a trade and its publication by SEC (Form 4) is 5 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Jay Bernard Dent
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 6,000 shares0Common StockSEC:0001096481-11-000015:0
- 8,000 shares0Common StockSEC:0001096481-11-000015:1
- 2,700 shares0Common StockSEC:0001096481-11-000015:2
- 6,000 shares@ US$1.94Common StockSEC:0001096481-11-000010:0
- 2,700 shares@ US$1.94Common StockSEC:0001096481-09-000030:0Canonical exit: 11 Nov 2009 (T+90)
- 8,000 shares@ US$1.95Common StockSEC:0001096481-09-000030:1Canonical exit: 11 Nov 2009 (T+90)
- 6,000 shares@ US$1.96Common StockSEC:0001096481-09-000030:2Canonical exit: 11 Nov 2009 (T+90)
7 of 7 declarations